Filgrastim Active Not Recruiting Phase 3 Trials for Uterine Corpus Leiomyosarcoma / Stage I Uterine Sarcoma / Stage I Uterine Sarcoma AJCC v7 Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01533207Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery